Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very ...

Stifel analysts revised their price target for FTAI Aviation (NASDAQ:FTAI) shares, lowering it significantly to $100 from the ...

Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...

Stifel analysts initiated coverage on Cytokinetics shares (NASDAQ:CYTK), assigning a Buy rating and setting a price target of ...

Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...

Local leaders descended upon the Stifel Fine Arts Center this evening for the Leadership Wheeling Kickoff Reception for 2025. Leadership Wheeling is a program ...

David Swartz, a senior equity analyst at Morningstar Research Services, told Retail Dive that VF has been “cutting costs and ...

Vail Resorts issued its annual early season update to investors on Thursday, reporting that season-to-date total skier visits ...

Stantec (TSE:STN – Free Report) (NYSE:STN) had its price objective boosted by Raymond James from C$120.00 to C$130.00 in a ...

TD Cowen has recently reiterated Nextdecade Corp (NEXT) stock to Buy rating, as announced on June 6, 2024, according to Finviz. Earlier, on August 16, 2023, Wolfe Research had raised the stock from a ...